Molecular mechanisms of leukemogenesis by AML1/EVI-1

Oncogene

Volumn 23, Issue 24, 2004, Pages 4263-4269

  Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

AML1 EVI 1; Apoptosis; Dominant negative effects; JNK; TGF ; Transcription factor

Indexed keywords

HISTONE DEACETYLASE; HYBRID PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; EVI1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; RUNX1 PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; APOPTOSIS; BLAST CELL CRISIS; CHIMERA; CHROMOSOME TRANSLOCATION 3; CHRONIC MYELOID LEUKEMIA; DNA SEQUENCE; ENZYME SUBSTRATE; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MIXED MYELODYSPLASTIC MYELOPROLIFERATIVE DISEASE; MOLECULAR GENETICS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION INITIATION; ZINC FINGER MOTIF; CELL DIVISION; DOMINANT GENE; DRUG ANTAGONISM; GENETICS; LEUKEMIA; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; PROTO ONCOGENE;

CELL DIVISION; CLONING, MOLECULAR; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENES, DOMINANT; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 2942602707     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207777     Document Type: Review

References (28)

1. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M and Ito Y. (1993). Oncogene, 8, 809-814.
2. Daga A, Tighe JE and Calabi F. (1992). Nature, 356, 484.
3. Huang G, Shigesada K, Ito K, Wee H-J, Yokomozo T and Ito Y. (2001). EMBO J., 20, 723-733.
4. Izutsu K, Kurokawa M, Imai Y, Ichikawa M, Asai T, Maki K, Mitani K and Hirai H. (2002). Oncogene, 21, 2695-2703.
5. Izutsu K, Kurokawa M, Imai Y, Maki K, Mitani K and Hirai H. (2001). Blood, 97, 2815-2822.
6. Kitabayashi I, Yokoyama A, Shimizu K and Ohki M. (1998). EMBO J., 17, 2994-3004.
7. Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y and Hirai H. (1998a). Blood, 92, 4003-4012.
8. Kurokawa M, Mitani K, Irie K, Matsuyama T, Takahashi T, Chiba S, Yazaki Y, Matsumoto K and Hirai H. (1998b). Nature, 394, 92-94.
9. Kurokawa M, Mitani K, Yamagata T, Takahashi T, Izutsu K, Ogawa S, Moriguchi T, Nishida E, Yazaki Y and Hirai H. (2000). EMBO J., 19, 2958-2968.
10. Kurokawa M, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte ON and Hirai H. (1995). Oncogene, 11, 833-840.
11. Mitani K, Ogawa S, Tanaka T, Kurokawa M, Yazaki Y and Hirai H. (1995). Br. J. Haematol., 90, 711-714.
12. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Misao O and Hirai H. (1994). EMBO J., 13, 504-510.
13. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y and Ohki M. (1991). Proc. Natl. Acad. Sci. USA, 88, 10431-10434.
14. Morishita K, Parganas E, Douglass EC and Ihle JN. (1990). Oncogene, 5, 963-971.
15. Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB and Ihle JN. (1992). Proc. Natl. Acad. Sci. USA, 89, 3937-3941.
16. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG and Ihle JN. (1988). Cell, 54, 831-840.
17. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y and Shigesada K. (1993a). Virology, 194, 314-331.
18. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K and Ito Y. (1993b). Proc. Natl. Acad. Sci. USA, 90, 6859-6863.
19. Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y and Hirai H. (1996a). Leukemia, 10, 788-794.
20. Ogawa S, Kurokawa M, Tanaka T, Mitani K, Inazawa J, Hanagaishi A, Tanaka K, Matsuo Y, Minowada J, Tsubota T, Yazaki Y and Hirai H. (1996b). Oncogene, 13, 183-191.
21. Okuda T, van Deursen J, Hiebert SW, Grosveld G and Downing JR. (1996). Cell, 84, 321-330.
22. Sasaki K, Yagi H, Bronson RT, Tomonaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T and Komori T. (1996). Proc. Natl. Acad. Sci. USA, 93, 12359-12363.
23. Tanaka K, Tanaka T, Kurokawa M, Imai Y, Ogawa S, Mitani K, Yazaki Y and Hirai H. (1998). Blood, 91, 1688-1699.
24. Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y and Hirai H. (1995). Mol. Cell. Biol., 15, 2383-2392.
25. Tanaka T, Nishida J, Mitani K, Ogawa S, Yazaki Y and Hirai H. (1994). J. Biol. Chem., 269, 24020-24026.
26. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae S-C, Komori T, Ito Y and Littman D. (2002). Cell, 111, 621-633.
27. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH and Speck NA. (1996a). Proc. Natl. Acad. Sci. USA. 93, 3444-3449.
28. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Borie JC, Bories JC, Alt EW, Ryan G, Liu PP, Wynsaw-Boris A, Binder M, Marin-Padilla M, Sharpe AH and Speck NA. (1996b). Cell, 87, 697-708.